EZH2 es un marcador pronóstico clave y una diana terapéutica en el hepatoblastoma agresivo y proliferativo

Fatma Zohra Khoubai1,2, Alexia Calovoulos1,2,3, Hélène Guillorit2

  • 1Univ. Bordeaux, INSERM, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancer, BMGIC, U1035, Bordeaux, F-33000, France.

Molecular cancer
|February 24, 2026
PubMed
Resumen

No abstract available in PubMed .